All news from Cardiology

CHOP Celebrates EC Approval of Only Gene Therapy for Patients with Inherited Retinal Disease

Children's Hospital of Philadelphia (CHOP) celebrates a pivotal moment in medicine: approval by the European Commission (EC) of LUXTURNA® (voretigene neparvovec), the first and only gene therapy for patients with an inherited retinal disease, last month. This also makes LUXTURNA the first gene therapy for a genetic disease that has received regulatory approval in both the U.S. and European Union (EU)

New PET Tracer Identified For Imaging Tau in Alzheimer's Disease Patients

In the diagnosis of Alzheimer's disease and the search for effective treatments, tau tangles in the brain have joined amyloid build-up as markers of the disease and potential therapeutic targets. In the December issue of The Journal of Nuclear Medicine, the featured article of the monthly reports on the identification of a promising second-generation positron emission tomography (PET) tracer for imaging and measuring tau pathology